Powered by
ANN ARBOR—BlueWillow Biologics, a firm founded in 1999 that is developing nanotechnology for healthcare applications, announced the availability of NanoBio Protect on Amazon. NanoBio Protect is an alcohol-free antiseptic solution that …
ANN ARBOR—After years of development, Nexletol, the new cholesterol-reducer from Ann Arbor’s Esperion Therapeutics Inc., is now on the market and available in pharmacies in the United States. Nexletol uses …
LANSING–The Michigan Economic Development Corp.’s Pure Michigan Business Connect program is now offering a free, online procurement platform to assist suppliers of critical health and human services across a broad …
CANTON TWP.—MMS Holdings Inc., a Canton Township-based contract research organization (CRO) for the pharmaceutical industry, announced the introduction of its Datacise Integrated Safety Explorer, which will debut at the Pharmaceutical …
ALLENDALE—QST Consultations Ltd. has announced that it has changed its name to Abond CRO Inc., launching the new brand through a new website and participation at participation at the Summit …
ANN ARBOR—Millendo Therapeutics Inc. (Nasdaq: MLND), the developer of new endocrine drugs, announced the promotion of Thomas Hoover to the newly created position of chief commercial officer. Hoover joined Millendo …
GRAND RAPIDS—Tetra Discovery Partners, a clinical-stage biotechnology company, announced the company’s name change to Tetra Therapeutics. The name change reflects the company’s transition from a company focused on discovery research …
FARMINGTON HILLS—Ocuphire Pharma Inc., a clinical-stage pharmaceutical company developing therapies to treat patients with a variety of ophthalmic disorders, announced that it has closed on over $5 million of financing. …
(Updated June 5 with stock price) ROCHESTER—OptimizeRx Corp. (Nasdaq: OPRX), the Rochester-based provider of digital communication services for pharmaceutical companies to patients and healthcare providers, has announced a proposed underwritten …
ANN ARBOR—An Ann Arbor company that has developed a system to screen cancer patients to precision-designed treatments that will be most effective for them has a new clinical development collaboration …